Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Hasin

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|January 26, 2022
Myocarditis after BNT162b2 Vaccination in Israeli AdolescentsDror Mevorach, Emilia Anis, Noa Cedar, et al.
Heart, Lung & Circulation|September 3, 2013
Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist deviceSalil V Deo, Vikas Sharma, Salah E Altarabsheh, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 25, 2012
Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantationSalil V Deo, Richard C Daly, Salah E Altarabsheh, et al.
Transplantation|January 18, 2013
Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantationRichard C Daly, Yan Topilsky, Lyle Joyce, et al.
The New England Journal of Medicine|July 14, 2006
Postexposure treatment with doxycycline for the prevention of tick-borne relapsing feverTal Hasin, Nadav Davidovitch, Regev Cohen, et al.
Heart & Lung : the Journal of Critical Care|June 9, 2019
The impact of left ventricular ejection fraction on heart failure patients with pulmonary hypertensionBarak Zafrir, Shemy Carasso, Sorel Goland, et al.
Mayo Clinic Proceedings|June 13, 2018
Hemodynamic Assessment of Patients With and Without Heart Failure Symptoms Supported by a Continuous-Flow Left Ventricular Assist DeviceRabea Asleh, Tal Hasin, Alexandros Briasoulis, et al.
American Heart Journal|May 7, 2020
Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction-Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trialHans-Dirk Duengen, Raymond J Kim, Doron Zahger, et al.
Circulation. Cardiovascular Imaging|September 24, 2011
Echocardiographic variables after left ventricular assist device implantation associated with adverse outcomeYan Topilsky, Tal Hasin, Jae K Oh, et al.
JACC. Cardiovascular Imaging|October 8, 2013
Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosisNowell M Fine, Yan Topilsky, Jae K Oh, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|January 26, 2022
Myocarditis after BNT162b2 Vaccination in Israeli AdolescentsDror Mevorach, Emilia Anis, Noa Cedar, et al.
Heart, Lung & Circulation|September 3, 2013
Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist deviceSalil V Deo, Vikas Sharma, Salah E Altarabsheh, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 25, 2012
Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantationSalil V Deo, Richard C Daly, Salah E Altarabsheh, et al.
Transplantation|January 18, 2013
Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantationRichard C Daly, Yan Topilsky, Lyle Joyce, et al.
The New England Journal of Medicine|July 14, 2006
Postexposure treatment with doxycycline for the prevention of tick-borne relapsing feverTal Hasin, Nadav Davidovitch, Regev Cohen, et al.
Heart & Lung : the Journal of Critical Care|June 9, 2019
The impact of left ventricular ejection fraction on heart failure patients with pulmonary hypertensionBarak Zafrir, Shemy Carasso, Sorel Goland, et al.
Mayo Clinic Proceedings|June 13, 2018
Hemodynamic Assessment of Patients With and Without Heart Failure Symptoms Supported by a Continuous-Flow Left Ventricular Assist DeviceRabea Asleh, Tal Hasin, Alexandros Briasoulis, et al.
American Heart Journal|May 7, 2020
Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction-Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trialHans-Dirk Duengen, Raymond J Kim, Doron Zahger, et al.
Circulation. Cardiovascular Imaging|September 24, 2011
Echocardiographic variables after left ventricular assist device implantation associated with adverse outcomeYan Topilsky, Tal Hasin, Jae K Oh, et al.
JACC. Cardiovascular Imaging|October 8, 2013
Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosisNowell M Fine, Yan Topilsky, Jae K Oh, et al.
Pageof 10